HEREDITARY HEMORRHAGIC TELANGIECTASIA
Clinical trials for HEREDITARY HEMORRHAGIC TELANGIECTASIA explained in plain language.
Never miss a new study
Get alerted when new HEREDITARY HEMORRHAGIC TELANGIECTASIA trials appear
Sign up with your email to follow new studies for HEREDITARY HEMORRHAGIC TELANGIECTASIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Drug trial targets debilitating bleeding disorder
Disease control OngoingThis study is testing whether the drug bevacizumab can help control chronic bleeding and severe anemia in adults with Hereditary Hemorrhagic Telangiectasia (HHT), a genetic disorder that causes fragile, abnormal blood vessels. Participants receive the drug for 24 weeks while rese…
Matched conditions: HEREDITARY HEMORRHAGIC TELANGIECTASIA
Phase: PHASE2 • Sponsor: Hanny Al-Samkari, MD • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New hope for controlling debilitating nosebleeds in rare disease
Disease control OngoingThis study is testing whether a drug called pazopanib can help people with hereditary hemorrhagic telangiectasia (HHT), a genetic disorder that causes frequent, severe nosebleeds and anemia. About 70 participants will take either pazopanib or a placebo pill daily for 24 weeks to …
Matched conditions: HEREDITARY HEMORRHAGIC TELANGIECTASIA
Phase: PHASE2, PHASE3 • Sponsor: Cure HHT • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC